iShares Biotechnology ETF $IBB Holdings Lifted by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 7.9% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 105,706 shares of the financial services provider’s stock after buying an additional 7,750 shares during the period. Thrivent Financial for Lutherans owned 0.26% of iShares Biotechnology ETF worth $13,373,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at $201,000. Kovitz Investment Group Partners LLC raised its stake in shares of iShares Biotechnology ETF by 126.2% during the first quarter. Kovitz Investment Group Partners LLC now owns 4,107 shares of the financial services provider’s stock valued at $525,000 after purchasing an additional 2,291 shares in the last quarter. Quantbot Technologies LP bought a new stake in shares of iShares Biotechnology ETF during the first quarter valued at about $1,519,000. Erste Asset Management GmbH lifted its holdings in iShares Biotechnology ETF by 61.5% in the first quarter. Erste Asset Management GmbH now owns 63,000 shares of the financial services provider’s stock worth $8,058,000 after purchasing an additional 24,000 shares during the period. Finally, Tradition Wealth Management LLC grew its position in iShares Biotechnology ETF by 3.5% in the 1st quarter. Tradition Wealth Management LLC now owns 57,817 shares of the financial services provider’s stock valued at $7,395,000 after buying an additional 1,967 shares in the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

iShares Biotechnology ETF stock opened at $167.53 on Thursday. iShares Biotechnology ETF has a 52 week low of $107.43 and a 52 week high of $174.40. The company’s 50-day moving average price is $162.62 and its two-hundred day moving average price is $144.71.

iShares Biotechnology ETF Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 19th. Investors of record on Tuesday, December 16th will be paid a dividend of $0.1831 per share. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date is Tuesday, December 16th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.